Eléments de l'association

	D. Cunningham	6
	Oxaliplatine	5
	D. Cunningham *Sauf* Oxaliplatine"	4
	Oxaliplatine *Sauf* D. Cunningham"	3
	D. Cunningham Et Oxaliplatine	2
	D. Cunningham Ou Oxaliplatine	9
	*Corpus*	11069

List of bibliographic references

Number of relevant bibliographic references: 2.

Ident.	Authors (with country if any)	Title
002731	D. Cunningham [Royaume-Uni] ; B. Sirohi [Royaume-Uni] ; A. Pluzanska [Pologne] ; B. Utracka-Hutka [Pologne] ; J. Zaluski [Pologne] ; R. Glynne-Jones [Royaume-Uni] ; P. Koralewski [Pologne] ; J. Bridgewater [Royaume-Uni] ; P. Mainwaring [Australie] ; H. Wasan [Royaume-Uni] ; J.-Y. Wang [Taïwan] ; C. Szczylik [Pologne] ; P. Clingan [Australie] ; R. T. T. Chan [Hong Kong] ; I. Tabah-Fisch [France] ; J. Cassidy [Royaume-Uni]	Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
002859	E. Van Cutsem [Belgique] ; F. Rivera [Espagne] ; S. Berry [Canada] ; A. Kretzschmar [Allemagne] ; M. Michael [Australie] ; M. Dibartolomeo [Italie] ; M.-A. Mazier [France] ; J.-L. Canon [Belgique] ; V. Georgoulias [Grèce] ; M. Peeters [Belgique] ; J. Bridgewater ; D. Cunningham	Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024